Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carveol SCHEMBL26201044 | 1.00 | TSHR (1.00) | TSHRTP53ALOX15LMNAALDH1A1 | |
| Carveol SCHEMBL15011317 | 1.00 | TSHR (1.00) | TSHRTP53ALOX15LMNAALDH1A1 | |
| Carveol SCHEMBL180292 | 1.00 | TSHR (1.00) | TSHRTP53ALOX15LMNAALDH1A1 | |
| Carveol SCHEMBL18339543 | 1.00 | TSHR (1.00) | TSHRTP53ALOX15LMNAALDH1A1 | |
| Carveol SCHEMBL14763904 | 1.00 | TSHR (1.00) | TSHRTP53ALOX15LMNAALDH1A1 | |
| Carveol SCHEMBL20201316 | 1.00 | TSHR (1.00) | TSHRTP53ALOX15LMNAALDH1A1 | |
| Carveol SCHEMBL15011580 | 1.00 | TSHR (1.00) | TSHRTP53ALOX15LMNAALDH1A1 | |
| Carveol SCHEMBL56868 | 1.00 | TSHR (1.00) | TSHRTP53ALOX15LMNAALDH1A1 | |
| Carveol SCHEMBL20586300 | 1.00 | TSHR (1.00) | TSHRTP53ALOX15LMNAALDH1A1 | |
| Carveol SCHEMBL23706303 | 0.88 | TSHR (0.78) | TSHRTP53ALOX15LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598425-A1 | DETECTION OF LIVER DISEASE | Owlstone Medical Limited (GB) | 2025-08-13 | — | — | EP | claimed |
| CN-119709448-A | Construction and application of biosynthesis of (-) -carvone strain by utilizing saccharomyces cerevisiae and peroxisome localization | 中国科学院天津工业生物技术研究所 | 2025-03-28 | — | — | CN | claimed |
| CN-118583998-A | Method for rapidly identifying star anise and shikimia based on ultra-rapid gas-phase electronic nose and BP neural network | 江苏省中医院 | 2024-09-03 | — | — | CN | claimed |
| CN-114847309-B | Mixed extract of fructus Piperis Longi, flos Chrysanthemi Indici extract and application of the same in strawberry disease control | 湖北工程学院 | 2024-07-19 | — | — | CN | claimed |
| WO-2024074826-A1 | DETECTION OF LIVER DISEASE | OWLSTONE MEDICAL LIMITED (GB) | 2024-04-11 | — | — | WO | claimed |
| CN-116120989-B | Spice with sweet fruit flavor and compound flavor and preparation method and application thereof | 云南中烟工业有限责任公司 | 2024-01-19 | — | — | CN | claimed |
| WO-2023187598-A1 | COMPOSITIONS AND METHODS | BIBLICAL LANDS LTD (IL) | 2023-10-05 | — | — | WO | claimed |
| EP-4243619-A1 | CITRUS OIL EXTRACT | Firmenich SA (CH) | 2023-09-20 | — | — | EP | claimed |
| EP-4229639-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS Global Biopharma, Inc. (CA) | 2023-08-23 | — | — | EP | claimed |
| CN-116261399-A | Citrus oil extract | 弗门尼舍有限公司 | 2023-06-13 | — | — | CN | claimed |
| US-20060127517-A1 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | META PROTEOMICS, LLC | 2006-06-15 | — | — | US | claimed |
| CN-1742953-A | Plant cell regulator | YUKUN LIAO (HK) | 2006-03-08 | — | — | CN | claimed |
| EP-1558271-A4 | COMPOSITIONS THAT TREAT OR INHIBIT PATHOLOGICAL CONDITIONS ASSOCIATED WITH INFLAMMATORY RESPONSE | METAPROTEOMICS LLC (US) | 2006-01-11 | — | — | EP | claimed |
| US-20050260725-A1 | Process for the preparation of trans-carveol | EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH (CH) | 2005-11-24 | — | — | US | claimed |
| EP-1558271-A2 | COMPOSITIONS THAT TREAT OR INHIBIT PATHOLOGICAL CONDITIONS ASSOCIATED WITH INFLAMMATORY RESPONSE | Metaproteomics, LLC (US) | 2005-08-03 | — | — | EP | claimed |
| US-20040151792-A1 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | FORTRESS CREDIT CORP. (AS COLLATERAL AGENT) | 2004-08-05 | — | — | US | claimed |
| WO-2004037180-A2 | COMPOSITIONS THAT TREAT OR INHIBIT PATHOLOGICAL CONDITIONS ASSOCIATED WITH INFLAMMATORY RESPONSE | METAPROTEOMICS, LLC (US) | 2004-05-06 | — | — | WO | claimed |
| US-20040086580-A1 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | META PROTEOMICS, LLC | 2004-05-06 | — | — | US | claimed |
| EP-1205556-A1 | Process for the preparation of trans-carveol | AVENTIS ANIMAL NUTRITION S.A. (FR) | 2002-05-15 | — | — | EP | claimed |
| US-3956404-A | PINENE, CUPROUS CHLORIDE OR BROMIDE, BENZOYL PEROXIDE, MIXING | LEVER BROTHERS COMPANY (US) | 1976-05-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040086580-A1 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | HPGDS, TPSB2, TPSG1 | TSHR 3439/4885TP53 1700/4885ALOX15 219/4885 |
| US-20040151792-A1 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | HPGDS, TPSB2, HMGB2 | TSHR 3592/4885TP53 1863/4885ALOX15 147/4885 |
| US-20060127517-A1 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | HPGDS, TPSB2, TPSG1 | TSHR 3439/4885TP53 1700/4885ALOX15 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.